|
No product was returned, as the footswitch is not manufactured by solta.Therefore, no further evaluation can be performed.A delay in a procedure due to an inoperable foot pedal/switch is identified in the vaserlipo system risk assessment.No nonconformities or anomalies were found related to this complaint when reviewing the device history record for the vaser system.The trend analysis, risk analysis, and directions for use review were considered acceptable, with the product performing within anticipated rates.Based on the available information, no causal factors can be determined, and no conclusions can be found.At this time, no capa is necessary.
|